What this study is
The goal of this clinical trial is to compare the efficacy of a standard intradialytic exercise program (control group) to an individualized, patient-centered, "Move-More" physical activity intervention (intervention group) in hemodialysis (HD) patients.
Exercise programs often fail to yield robust benefits for many HD patients, in part because the type and volume of exercise prescribed is inappropriate for a variety of reasons, and the benefits from these studies are often disappointing, as they are characterized by poor adherence, high dropout rates, and modest effects on physical function, body composition, cardiovascular disease risk, and other outcomes related to quality of life (QOL). To address this, the investigators have designed a novel physical activity intervention "Move More" that is designed to overcome many of the barriers to increasing physical activity in this population. This study aims to compare the efficacy of a standard intradialytic exercise program (control group) to an individualized, patient-centered, "Move-More" physical activity intervention (intervention group) in HD patients. The investigators primary hypothesis is that patients randomized to the Move More intervention will increase their physical activity levels more than those in the intradialytic exercise group.
The main question it aims to answer is:
- Does "Move More" increase the physical activity levels (minutes) measured through weekly minutes of physical activity and the LoPAQ questionnaire more than those in the standard intradialytic exercise program?
For secondary outcomes this study aims to answer the following:
- Does "Move More" improve the physical function of hemodialysis patients assessed by the short physical performance battery (SPBB) more than those in the standard intradialytic exercise program?
- Does "Move More" decrease fatigue assess by the SONG-HD survey more than those in the standard intradialytic exercise program?
- Does "Move More" decrease symptoms of depression assessed by PROMIS Depression Short Form 8a more than those in the standard intradialytic exercise program?
- Does "Move More" increase the amount of exercise measured through a point system more than those in the standard intradialytic exercise program?
- Does "Move More" improve blood pressure (BP) more than those in the standard intradialytic exercise program?
What's being tested
- "Move More" Personalized Exercise Program
Intervention · BEHAVIORAL
"Move More" - a personalized exercise program involving both in center and out-of-center exercise. Our novel intervention provides patient's the autonomy to choose the types of physical activity and exercise that they are willing and able to participate in. In brief, it involves working one-on-one with patients to develop an activity prescription that aims to get participants to "move more", by any means necessary.
- Intradialytic Exercise Program
Intervention · BEHAVIORAL
Those in the intradialytic exercise group will undergo a variety of exercises including intradialytic cycling and resistance ("strength training").
Study details
- Official title
- Development and Testing of an Innovative Patient-Centered Physical Activity Program for Hemodialysis Patients
- Sponsor
- University of Arizona
- Conditions
- Hemodialysis
- Enrolling
- 40 people
- Starts
- 2025-07-01
- Est. completion
- 2026-10
- Design
- Open-label, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- ≥ 18 years old (no upper age limit);
- Chronic hemodialysis for ≥ 3 months;
- No planned or expected change in dialysis modality, elective surgery, or relocation during the study period (24 weeks);
- Able to communicate in English or Spanish and provide written informed consent;
- Assessed to be safe and able to exercise by the Hemodialysis unit nephrologist
You can't join if
- Physical Activity: patients undergoing >150 minutes/week of prescribed PA at baseline will be excluded from the study.
- Physician Clearance: Patients who do not receive physician clearance to participate in the study will be excluded from the study.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openDCI Desert Dialysis
Tucson, Arizona, United States
- Patty Blankenship, RN · Contact(520) 327-0007patty.blankenship@dciinc.org
Recruiting
Study team
Sponsor
University of Arizona
Study ID STUDY00004405
Principal investigator
Kenneth R Wilud, PhD
University of Arizona
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.